Your browser is no longer supported. Please, upgrade your browser.
NanoVibronix, Inc.
Index- P/E- EPS (ttm)-0.99 Insider Own0.10% Shs Outstand19.31M Perf Week0.00%
Market Cap24.69M Forward P/E- EPS next Y- Insider Trans91.58% Shs Float13.68M Perf Month5.36%
Income-4.50M PEG- EPS next Q- Inst Own12.10% Short Float1.04% Perf Quarter55.26%
Sales0.60M P/S41.14 EPS this Y-26.10% Inst Trans59.27% Short Ratio0.04 Perf Half Y68.60%
Book/sh0.35 P/B3.37 EPS next Y- ROA-218.30% Target Price- Perf Year-57.86%
Cash/sh0.15 P/C7.71 EPS next 5Y- ROE-418.50% 52W Range0.54 - 3.50 Perf YTD54.43%
Dividend- P/FCF- EPS past 5Y39.60% ROI-417.10% 52W High-67.12% Beta-0.15
Dividend %- Quick Ratio10.40 Sales past 5Y21.20% Gross Margin26.10% 52W Low115.06% ATR0.18
Employees10 Current Ratio10.70 Sales Q/Q100.00% Oper. Margin- RSI (14)44.30 Volatility14.79% 12.35%
OptionableNo Debt/Eq0.00 EPS Q/Q46.40% Profit Margin- Rel Volume0.20 Prev Close1.18
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.90M Price1.15
Recom2.00 SMA20-13.34% SMA501.51% SMA200-5.16% Volume45,233 Change-2.47%
Mar-02-21 08:30AM  
Feb-10-21 08:00AM  
Feb-03-21 08:00AM  
Jan-22-21 11:12AM  
Jan-19-21 08:00AM  
Dec-11-20 08:00AM  
Dec-08-20 08:00AM  
Dec-07-20 05:10PM  
Dec-02-20 01:01PM  
Nov-16-20 06:12PM  
Oct-16-20 08:30AM  
Oct-08-20 09:00AM  
Sep-29-20 08:49AM  
Sep-22-20 08:36PM  
Aug-27-20 03:42PM  
Aug-24-20 10:58PM  
Aug-13-20 08:30AM  
Jul-07-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 08:00AM  
Apr-02-20 11:06AM  
Apr-01-20 08:00AM  
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FASHEK CHRISTOPHER MDirectorSep 29Buy0.7910,0007,88710,000Oct 09 04:07 PM